NCT00251160

Brief Summary

This trial will compare the effectiveness of electrothermal arthroscopic capsulorrhaphy (ETAC) to the current reference standard procedure, open inferior capsular shift (ICS), for the treatment of shoulder instability caused by ligamentous capsular redundancy. Multi-directional instability (MDI) and multi-directional laxity with anteroinferior instability (MDL-AII) are the two types of shoulder instabilities included in this trial. Hypothesis: There is no difference in disease-specific quality of life between patients undergoing an ETAC versus an open ICS for the treatment of shoulder instability caused by capsular ligamentous redundancy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
58

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Dec 1999

Longer than P75 for not_applicable

Geographic Reach
1 country

7 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 1999

Completed
5.9 years until next milestone

First Submitted

Initial submission to the registry

November 7, 2005

Completed
2 days until next milestone

First Posted

Study publicly available on registry

November 9, 2005

Completed
4.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2010

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2010

Completed
Last Updated

July 13, 2015

Status Verified

July 1, 2015

Enrollment Period

10.2 years

First QC Date

November 7, 2005

Last Update Submit

July 9, 2015

Conditions

Keywords

Multi-directional instabilityMDILigamentous laxityMulti-directional laxityMDL-AIIShoulder instabilityelectrothermal capsulorrhaphy, ETACinferior capsular shift, ICScapsular redundancy

Outcome Measures

Primary Outcomes (1)

  • Western Ontario Shoulder Instability (WOSI) Index

    Baseline, 3, 6, 12, 24 months post-operatively

Secondary Outcomes (5)

  • Constant score (European Shoulder Society)

    Baseline, 3, 6, 12, 24 months post-operatively

  • Recurrent instability

    Up to 24 months post-operatively

  • Complications

    Intra-operatively and up to 8 weeks post-operatively

  • Operative time

    Day of surgery

  • American Shoulder and Elbow Surgeon's Score (ASES)

    Baseline, 3, 6, 12, 24 months post-operatively

Study Arms (2)

ETAC

ACTIVE COMPARATOR
Procedure: Electrothermal arthroscopic capsulorrhaphy (ETAC)

Open ICS

ACTIVE COMPARATOR
Procedure: Open inferior capsular shift (ICS)

Interventions

The Oratec Vulcan Generator electro-thermal system (Oratec Interventions Inc., Menlo Park, CA, USA) delivers heat at 75C and 40 watts. An anterior portal is established above the superior border of the subscapularis tendon. For MDI patients, the heat probe is introduced through the posterior portal. The capsule is shrunk using a grid pattern until excess volume is diminished. The extent of the heat probe application is identical to the landmarks used for the open ICS. Care is taken to avoid applying heat to the capsule in the region from 5-7 o'clock within 1cm of the glenoid rim to avoid the axillary nerve. The method of heat application utilizes a grid pattern, which is less likely to cause dissolution of the capsule and subsequent catastrophic capsular loss.

Also known as: Heat probe
ETAC

MDI: lateral capsule released antero-superiorly from rotator interval to equator, posteriorly on the humeral neck. MDL-AII: release from the rotator interval to 7 o'clock (Right) or 5 o'clock (Left) position on humeral neck, to tighten the 2 bands of the inferior GH ligaments, middle GH ligament and rotator interval. Bone adjacent to the articular surface on the surgical neck of the humerus is roughened to create a bleeding bony bed. With the arm in 0deg flexion, 30deg abduction, 30deg external rotation, the inferior leaflet of the capsule is shifted superiorly and slightly laterally, and sutured to the rim of the capsule using a non-absorbable suture. Superior leaflet is shifted inferiorly and sutured. Subscapularis is repaired at its anatomic length using interrupted sutures.

Also known as: Open inferior capsular shift
Open ICS

Eligibility Criteria

Age14 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Ages 14 years or greater
  • Diagnosis of MDI or MDL-AII. Diagnosis will require two or more of the following:
  • Symptomatic translation (pain or discomfort) in one or more directions: anterior, inferior and/or posterior;
  • Ability to elicit unwanted glenohumeral translations that reliably produce symptoms with one of the following tests: the anterior and posterior apprehension tests, the anterior and posterior load and shift tests, the fulcrum test, the relocation test, the Fukuda test, and/or the push-pull or stress test with the patient supine;
  • Presence of a positive sulcus sign of 1 centimetre or greater gap that reproduces the patient's clinical symptoms of instability and should be both palpable and visible;
  • Symptoms of instability: subluxation or dislocation.
  • Written informed consent
  • Failed at least 6 months of non-operative treatment
  • Confirmed capsular-ligamentous redundancy as determined by diagnostic arthroscopy examination.

You may not qualify if:

  • Neurologic disorder (ie: axillary nerve injury; syringomyelia)
  • Cases involving third party compensation
  • Patients with primary posterior instability
  • A bony abnormality (Hill Sachs/bony Bankart) on standard series of x-rays consisting of a minimum of an anteroposterior view, lateral in the scapular plane and an axillary view
  • Presence of a Bankart lesion on arthroscopic exam of the joint
  • Presence of an unstable biceps anchor (ie: superior labral anterior and posterior \[SLAP\] lesion) on arthroscopic exam of the joint
  • Presence of a full-thickness rotator cuff tear.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (7)

University of Calgary Sport Medicine Centre

Calgary, Alberta, T2N 1N4, Canada

Location

Grey Nuns Community Hospital

Edmonton, Alberta, T6L 5X8, Canada

Location

Royal Columbian Hospital

New Westminster, British Columbia, V3L 3W7, Canada

Location

Pan Am Medical and Surgical Centre

Winnipeg, Manitoba, R3M 3E4, Canada

Location

Hamilton General Hospital

Hamilton, Ontario, L8L 5G8, Canada

Location

Fowler Kennedy Sport Medicine Centre

London, Ontario, N6A 3K7, Canada

Location

St. Joseph's Health Centre

London, Ontario, N6A 4L6, Canada

Location

Related Publications (2)

  • Mohtadi NG, Hollinshead RM, Ceponis PJ, Chan DS, Fick GH. A multi-centre randomized controlled trial comparing electrothermal arthroscopic capsulorrhaphy versus open inferior capsular shift for patients with shoulder instability: protocol implementation and interim performance: lessons learned from conducting a multi-centre RCT [ISRCTN68224911; NCT00251160]. Trials. 2006 Feb 2;7:4. doi: 10.1186/1745-6215-7-4.

    PMID: 16542033BACKGROUND
  • Mohtadi NG, Kirkley A, Hollinshead RM, McCormack R, MacDonald PB, Chan DS, Sasyniuk TM, Fick GH, Paolucci EO; Joint Orthopaedic Initiative for National Trials of the Shoulder-Canada. Electrothermal arthroscopic capsulorrhaphy: old technology, new evidence. A multicenter randomized clinical trial. J Shoulder Elbow Surg. 2014 Aug;23(8):1171-80. doi: 10.1016/j.jse.2014.02.022. Epub 2014 Jun 15.

Related Links

MeSH Terms

Conditions

Shoulder DislocationJoint Instability

Condition Hierarchy (Ancestors)

Joint DislocationsJoint DiseasesMusculoskeletal DiseasesWounds and InjuriesShoulder Injuries

Study Officials

  • Nicholas Mohtadi, MD, FRCSC

    University of Calgary Sport Medicine Centre

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Associate Professor

Study Record Dates

First Submitted

November 7, 2005

First Posted

November 9, 2005

Study Start

December 1, 1999

Primary Completion

February 1, 2010

Study Completion

February 1, 2010

Last Updated

July 13, 2015

Record last verified: 2015-07

Locations